These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24124705)

  • 61. Evidence-based and unlicensed indications for proton pump inhibitors and patients' preferences for discontinuation: a pilot study in a sample of Italian community pharmacies.
    Pasina L; Urru SA; Mandelli S; Giua C; Minghetti P;
    J Clin Pharm Ther; 2016 Apr; 41(2):220-3. PubMed ID: 26931180
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Strategies for Effective Discontinuation of Proton Pump Inhibitors.
    Kim J; Blackett JW; Jodorkovsky D
    Curr Gastroenterol Rep; 2018 May; 20(6):27. PubMed ID: 29767318
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cardiovascular and non-cardiovascular concerns with proton pump inhibitors: Are they safe?
    Corsonello A; Lattanzio F
    Trends Cardiovasc Med; 2019 Aug; 29(6):353-360. PubMed ID: 30389278
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Side Effects of Long-Term Proton Pump Inhibitor Use: A Review.
    Haastrup PF; Thompson W; Søndergaard J; Jarbøl DE
    Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):114-121. PubMed ID: 29658189
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Gastric acid rebound after a proton pump inhibitor: Narrative review of literature].
    Rochoy M; Dubois S; Glantenet R; Gautier S; Lambert M
    Therapie; 2018; 73(3):237-246. PubMed ID: 29195714
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Proton Pump Inhibitors, Kidney Damage, and Mortality: An Updated Narrative Review.
    Edinoff AN; Wu NW; Parker K; Dudossat E; Linquest L; Flanagan CJ; Dharani A; Patel H; Willett O; Cornett EM; Kaye AM; Kaye AD
    Adv Ther; 2023 Jun; 40(6):2693-2709. PubMed ID: 37140707
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Long-term use of proton pump inhibitors: who needs prophylaxis?].
    Scheurlen M
    Internist (Berl); 2013 Mar; 54(3):366-72. PubMed ID: 23404267
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications.
    Heidelbaugh JJ
    Ther Adv Drug Saf; 2013 Jun; 4(3):125-33. PubMed ID: 25083257
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Association between proton pump inhibitor use and anemia: a retrospective cohort study.
    Sarzynski E; Puttarajappa C; Xie Y; Grover M; Laird-Fick H
    Dig Dis Sci; 2011 Aug; 56(8):2349-53. PubMed ID: 21318590
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Overutilization of proton-pump inhibitors: what the clinician needs to know.
    Heidelbaugh JJ; Kim AH; Chang R; Walker PC
    Therap Adv Gastroenterol; 2012 Jul; 5(4):219-32. PubMed ID: 22778788
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Acid suppressing therapy as a risk factor for Candida esophagitis.
    Daniell HW
    Dis Esophagus; 2016 Jul; 29(5):479-83. PubMed ID: 25833302
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Outcome after Discontinuation of Proton Pump Inhibitors at a Residential Care Site: Quality Improvement Project.
    Lee C; Lo A; Ubhi K; Milewski M
    Can J Hosp Pharm; 2017; 70(3):215-223. PubMed ID: 28680175
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Adverse effects of long-term proton-pump inhibitor therapy on adults].
    Igaz I; Simonyi G; Balogh S; Szathmári M
    Orv Hetil; 2018 May; 159(19):735-740. PubMed ID: 29730946
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Complications of Proton Pump Inhibitor Therapy.
    Vaezi MF; Yang YX; Howden CW
    Gastroenterology; 2017 Jul; 153(1):35-48. PubMed ID: 28528705
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Systematic review: hypomagnesaemia induced by proton pump inhibition.
    Hess MW; Hoenderop JG; Bindels RJ; Drenth JP
    Aliment Pharmacol Ther; 2012 Sep; 36(5):405-13. PubMed ID: 22762246
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors.
    Maideen NMP
    Chonnam Med J; 2023 May; 59(2):115-127. PubMed ID: 37303818
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The risks of long-term use of proton pump inhibitors: a critical review.
    Jaynes M; Kumar AB
    Ther Adv Drug Saf; 2019; 10():2042098618809927. PubMed ID: 31019676
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Proton pump inhibitor - side effects and complications of long-term proton pump inhibitor administration].
    Ueberschaer H; Allescher HD
    Z Gastroenterol; 2017 Jan; 55(1):63-74. PubMed ID: 28073136
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proton pump inhibitors and osteoporosis.
    Andersen BN; Johansen PB; Abrahamsen B
    Curr Opin Rheumatol; 2016 Jul; 28(4):420-5. PubMed ID: 27224743
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Chronic use of proton pump inhibitors: is the risk of osteoporosis and fractures real?].
    Martí-Cabrera M; Martí-Masanet M; Esplugues JV
    Gastroenterol Hepatol; 2011 Apr; 34(4):271-7. PubMed ID: 21419526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.